Schizophrenia News and Research

Latest Schizophrenia News and Research

Tofacitinib shows promise in active ulcerative colitis

Tofacitinib can induce a clinical response in the majority of patients with moderate to severe, active ulcerative colitis, a placebo-controlled trial has shown.

16 Aug 2012

Happiness undiminished in FES patients

Results from a Canadian study suggest that patients who have experienced a first episode of schizophrenia are just as happy as mentally healthy individuals, despite significant functional impairment.

16 Aug 2012

TG2 plays a key role in serotonin deficiency associated with depression

Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say.

15 Aug 2012

Scientists use supercomputers to reveal links between known risk factors and heart biology

About 25,000 Danes currently live with congenital heart defects. Both heredity and environment play a role for these malformations, but exactly how various risk factors influence the development of the heart during pregnancy has been a mystery until now.

15 Aug 2012

Brain language structures altered in patients at genetic risk for schizophrenia

Mentally healthy individuals with a family history of schizophrenia display alterations in brain areas associated with language, US researchers report.

14 Aug 2012

Sleep impairment linked to bipolar disorder course in teens

Sleep impairment plays a significant role in the course of bipolar disorder among adolescents, US study results suggest.

14 Aug 2012

Schizophrenia and the immune system: an interview with Prof Cyndi Shannon Weickert

Schizophrenia is the most disabling disease impacting youth today. It impacts 1% of the total population and typically causes withdrawal from society, loss in IQ, disordered thought and speech, hallucinations and delusions.

14 Aug 2012

Tofacitinib efficacy suggested for rheumatoid arthritis

The novel oral Janus kinase inhibitor tofacitinib significantly reduces signs and symptoms of rheumatoid arthritis, report two phase III trials published in TheNew England Journal of Medicine.

13 Aug 2012

Epigenetic factors involved in treatment-resistance to schizophrenia drugs

Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.

13 Aug 2012

Scientists discover how pten gene causes brain changes that lead to autism-like behavior

Scientists affiliated with the UC Davis MIND Institute have discovered how a defective gene causes brain changes that lead to the atypical social behavior characteristic of autism. The research offers a potential target for drugs to treat the condition.

13 Aug 2012

Thyroid disease common in vitiligo patients

Results from a systematic review and meta analysis suggest that thyroid disease is a common comorbidity in people with vitiligo.

10 Aug 2012

Allergies appear to lower brain tumor risk

Testing positive for immunoglobulin E, a biomarker of allergy, reduces a person’s risk for developing glioma, show study findings.

10 Aug 2012

Mirror-gazing illusion more intense in schizophrenia

Patients with schizophrenia report more intense perceptual illusions during the mirror-gazing task than do mentally healthy people, report researchers who also found that the patients were more likely to believe their illusions were real.

10 Aug 2012

Four predictors for relapse in FEP patients identified

Medication non-adherence, persistent substance use disorder, carers' critical comments, and poorer premorbid adjustment are significant predictors for relapse in patients treated for a first episode of psychosis, a review and meta-analysis of published studies shows.

9 Aug 2012

Two major classes of brain cells repress neural activity in specific mathematical ways

The brain has billions of neurons, arranged in complex circuits that allow us to perceive the world, control our movements and make decisions. Deciphering those circuits is critical to understanding how the brain works and what goes wrong in neurological disorders.

9 Aug 2012

Scientists develop new way to study role of GABA-A receptors in various disorders

A new way to study the role of a critical neurotransmitter in disorders such as epilepsy, anxiety, insomnia, depression, schizophrenia, and alcohol addiction has been developed by a group of scientists led by Gong Chen, an associate professor of biology at Penn State University.

9 Aug 2012

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.

8 Aug 2012

Schizophrenia may be linked to immune function

New Australian research shows that the brains of people with schizophrenia may be under attack by the immune system, providing the strongest evidence to date of a link between immune function and schizophrenia.

7 Aug 2012

Blood levels of IL-6 protein may also serve as red flag for relapse in schizophrenia patients

Blood levels of a protein that helps regulate inflammation may also serve as a red flag for relapse in some schizophrenia patients, researchers said.

7 Aug 2012

Studies in mice reveal how mood-altering drugs may affect brain stem cells

Working with mice, Johns Hopkins researchers say they have figured out how stem cells found in a part of the brain responsible for learning, memory and mood regulation decide to remain dormant or create new brain cells. Apparently, the stem cells "listen in" on the chemical communication among nearby neurons to get an idea about what is stressing the system and when they need to act.

7 Aug 2012

Schizophrenia News and Research

Latest Schizophrenia News and Research

Tofacitinib shows promise in active ulcerative colitis

Happiness undiminished in FES patients

TG2 plays a key role in serotonin deficiency associated with depression

Scientists use supercomputers to reveal links between known risk factors and heart biology

Brain language structures altered in patients at genetic risk for schizophrenia

Sleep impairment linked to bipolar disorder course in teens

Schizophrenia and the immune system: an interview with Prof Cyndi Shannon Weickert

Tofacitinib efficacy suggested for rheumatoid arthritis

Epigenetic factors involved in treatment-resistance to schizophrenia drugs

Scientists discover how pten gene causes brain changes that lead to autism-like behavior

Thyroid disease common in vitiligo patients

Allergies appear to lower brain tumor risk

Mirror-gazing illusion more intense in schizophrenia

Four predictors for relapse in FEP patients identified

Two major classes of brain cells repress neural activity in specific mathematical ways

Scientists develop new way to study role of GABA-A receptors in various disorders

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Schizophrenia may be linked to immune function

Blood levels of IL-6 protein may also serve as red flag for relapse in schizophrenia patients

Studies in mice reveal how mood-altering drugs may affect brain stem cells

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in